CN Patent

CN114728974B — 作为btk抑制剂的吡咯并嘧啶类化合物及其应用

Assigned to Zhejiang Longchuan Biomedical Technology Co ltd · Expires 2023-09-19 · 3y expired

What this patent protects

本发明公开了一种吡咯并嘧啶类化合物，及其在制备BTK蛋白激酶抑制剂相关疾病的药物中的应用。具体公开了式(III)所示化合物及其药学上可接受的盐。

USPTO Abstract

本发明公开了一种吡咯并嘧啶类化合物，及其在制备BTK蛋白激酶抑制剂相关疾病的药物中的应用。具体公开了式(III)所示化合物及其药学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN114728974B
Jurisdiction
CN
Classification
—
Expires
2023-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Longchuan Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.